| __timestamp | Bausch Health Companies Inc. | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2254600000 | 54823000000 |
| Thursday, January 1, 2015 | 2645000000 | 76691000000 |
| Friday, January 1, 2016 | 2611000000 | 87477000000 |
| Sunday, January 1, 2017 | 2548000000 | 89052000000 |
| Monday, January 1, 2018 | 2351000000 | 100745000000 |
| Tuesday, January 1, 2019 | 2350000000 | 91915000000 |
| Wednesday, January 1, 2020 | 2249000000 | 95905000000 |
| Friday, January 1, 2021 | 2394000000 | 104442000000 |
| Saturday, January 1, 2022 | 2364000000 | 104437000000 |
| Sunday, January 1, 2023 | 2559000000 | 112009000000 |
| Monday, January 1, 2024 | 121134000000 |
Igniting the spark of knowledge
In the ever-evolving landscape of the healthcare and retail sectors, Walgreens Boots Alliance, Inc. and Bausch Health Companies Inc. stand as titans. From 2014 to 2023, Walgreens consistently outpaced Bausch in cost of revenue, reflecting its expansive operations. Walgreens' cost of revenue surged by approximately 104% over this period, peaking in 2023. In contrast, Bausch's figures remained relatively stable, with a modest 14% increase. This disparity highlights Walgreens' aggressive growth strategy and market dominance. However, the data for 2024 is incomplete, leaving room for speculation on future trends. As these companies navigate the complexities of their industries, understanding their financial trajectories offers valuable insights into their strategic priorities and market positioning.
Cost of Revenue Trends: Johnson & Johnson vs Walgreens Boots Alliance, Inc.
Cost of Revenue Comparison: Amgen Inc. vs Walgreens Boots Alliance, Inc.
Comparing Cost of Revenue Efficiency: Bristol-Myers Squibb Company vs Walgreens Boots Alliance, Inc.
Cost of Revenue Trends: Zoetis Inc. vs Walgreens Boots Alliance, Inc.
Cost of Revenue Trends: Bio-Techne Corporation vs Walgreens Boots Alliance, Inc.
Cost of Revenue Trends: Walgreens Boots Alliance, Inc. vs Amneal Pharmaceuticals, Inc.
Walgreens Boots Alliance, Inc. vs Xenon Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Walgreens Boots Alliance, Inc. vs ADMA Biologics, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Walgreens Boots Alliance, Inc. and Vericel Corporation's Expenses
Cost of Revenue Trends: Amneal Pharmaceuticals, Inc. vs Bausch Health Companies Inc.
Cost Insights: Breaking Down Bausch Health Companies Inc. and Vericel Corporation's Expenses
Comparing Cost of Revenue Efficiency: Bausch Health Companies Inc. vs Mesoblast Limited